Jonathan Tackett, DO
Family Medicine · Prestonsburg, KYNPI 1922369974
Payments from drug & device makers
Across 170 payments — averaging $16.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$726
- AbbVie$310
- GSK$218
- Pfizer$204
- Novo Nordisk$194
- Johnson & Johnson$157
- plus $962 from 21 others
What the payments were for
- Food & beverage$2,770100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 44 | $726 |
| AbbVie | 17 | $310 |
| GSK | 13 | $218 |
| Pfizer | 13 | $204 |
| Novo Nordisk | 11 | $194 |
| Johnson & Johnson(2 entities) | 10 | $157 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $117 |
| AstraZeneca | 8 | $104 |
| Bayer | 7 | $98 |
| Lilly USA, LLC | 6 | $92 |
| Biohaven Pharmaceuticals, Inc. | 3 | $80 |
| Abbott | 4 | $69 |
| Amgen | 4 | $56 |
| Merck | 4 | $56 |
| Dexcom, Inc. | 2 | $36 |
| Boston Scientific | 2 | $35 |
| Idorsia Pharmaceuticals US Inc | 2 | $33 |
| Daiichi Sankyo Inc. | 2 | $31 |
| Exact Sciences | 2 | $31 |
| Grifols USA, LLC | 1 | $18 |
| Nestle Healthcare Nutrition Inc. | 1 | $18 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $17 |
| Sunovion Pharmaceuticals Inc. | 1 | $16 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $16 |
| Mylan Specialty L.p. | 1 | $15 |
| Actelion Pharmaceuticals US, Inc. | 1 | $14 |
| Esperion Therapeutics, Inc. | 1 | $11 |
How this compares
$2,770 in reported general payments places this provider in the 75th percentile of 1,559 family medicine providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JanuviaSitagliptin Phosphate | 147 | $140,276 |
| OzempicSemaglutide | 111 | $113,512 |
| EliquisApixaban | 95 | $101,689 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 76 | $51,753 |
| JardianceEmpagliflozin | 46 | $44,698 |
| KerendiaFinerenone | 39 | $40,806 |
| FarxigaDapagliflozin Propanediol | 38 | $37,373 |
| TradjentaLinagliptin | 33 | $31,225 |
| LinzessLinaclotide | 42 | $29,981 |
| XareltoRivaroxaban | 26 | $19,864 |
| Spiriva HandihalerTiotropium Bromide | 11 | $15,540 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 75 | $10,823 |
| MyrbetriqMirabegron | 13 | $9,264 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 44 | $6,542 |
| SymbicortBudesonide/Formoterol Fumarate | 21 | $6,476 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckJanuvia | $56 | $140,276147 claims |
| Novo NordiskOzempic | $194 | $113,512111 claims |
| PfizerEliquis | $204 | $101,68995 claims |
| GSKTrelegy Ellipta, Incruse Ellipta | $218 | $56,03288 claims |
| AstraZenecaFarxiga, Symbicort | $104 | $43,84959 claims |
| BayerKerendia | $98 | $40,80639 claims |
| AbbVieLinzess, Synthroid | $310 | $31,93767 claims |
| Johnson & JohnsonXarelto | $157 | $19,86426 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,559 family medicine providers in Kentucky.
Other family medicine in Prestonsburg
- Debra HallPrestonsburg$12K
- Brian SmithVersailles$7.7M
- Barbara Fleming-PhillipsLexington$1.4M
- Christopher RhyneLouisville$1M
- Kruti PatelBurlington$463K
- Michael LovelaceLouisville$244K
- John RichardLexington$226K
- Diego MastronardiBowling Green$196K
- James TurnboPaducah$124K
- Eleida Tur OlivaLexington$113K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.